Mark Blick
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 21
- Chronic Myeloid Leukemia Treatments 17
-
- Glycosylation and Glycoproteins Research 5
- Co-authors
- Jordan U. Gutterman (15 shared papers)Razelle Kurzrock (8 shared papers)Michael G. Rosenblum (1 shared paper)Stephen A. Sherwin (1 shared paper)Moshe Talpaz (13 shared papers)Gabriel N. Hortobágyi (5 shared papers)Miloslav Beran (7 shared papers)Jae Y. Ro (5 shared papers)
- Journals
- Blood (7 papers)Cancer (3 papers)Hematological Oncology (2 papers)Biochemical and Biophysical Research Communications (2 papers)Journal of Leukocyte Biology (2 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Mark Blick
57 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 108
- Hematology 871
- Genetics 591
- Oncology 960
- Cancer Research 376
- Pathology and Forensic Medicine 352
Countries citing papers authored by Mark Blick
This map shows the geographic impact of Mark Blick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Blick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Blick more than expected).
Fields of papers citing papers by Mark Blick
This network shows the impact of papers produced by Mark Blick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Blick. The network helps show where Mark Blick may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Blick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I study of recombinant tumor necrosis factor in cancer patients. | 1987 | 386 |
| 2 | 1987 | 253 | |
| 3 | 1988 | 192 | |
| 4 | Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. | 1990 | 179 |
| 5 | 1989 | 168 | |
| 6 | 1991 | 149 | |
| 7 | c-erbB-2 amplification in node-negative human breast cancer. | 1989 | 110 |
| 8 | 1990 | 109 | |
| 9 | Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. | 1988 | 109 |
| 10 | 1988 | 101 | |
| 11 | 1988 | 89 | |
| 12 | 1988 | 83 | |
| 13 | Analysis of the epidermal growth factor receptor gene in fresh human head and neck tumors. | 1987 | 80 |
| 14 | 1988 | 71 | |
| 15 | 1987 | 67 | |
| 16 | 1987 | 55 | |
| 17 | Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia. | 1988 | 52 |
| 18 | Allele loss at the c-Ha-ras1 locus in human ovarian cancer. | 1989 | 50 |
| 19 | Bcl-1 gene rearrangements in B cell lymphoma. | 1988 | 43 |
| 20 | 1988 | 42 |
About Mark Blick
Mark Blick is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Pathology and Forensic Medicine, having authored 57 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (17 papers), Chronic Lymphocytic Leukemia Research (15 papers), HER2/EGFR in Cancer Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Acute Lymphoblastic Leukemia research (6 papers), Glycosylation and Glycoproteins Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Hematology (871 citations), Genetics (591 citations), Oncology (960 citations), Cancer Research (376 citations) and Pathology and Forensic Medicine (352 citations). Mark Blick has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Jordan U. Gutterman, Razelle Kurzrock, Michael G. Rosenblum, Stephen A. Sherwin, Moshe Talpaz, Gabriel N. Hortobágyi, Miloslav Beran, Jae Y. Ro, David M. Wildrick and José M. Trujillo. Their work appears in journals such as Blood, Cancer, Hematological Oncology, Biochemical and Biophysical Research Communications and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.